Designing effective exercise intervention trials for prostate cancer cohorts: a qualitative study on experiences and views of exercise oncology researchers.
Exercise oncology
Expert opinion
Prostate cancer
Trial design
Journal
BMC sports science, medicine & rehabilitation
ISSN: 2052-1847
Titre abrégé: BMC Sports Sci Med Rehabil
Pays: England
ID NLM: 101605016
Informations de publication
Date de publication:
30 Oct 2023
30 Oct 2023
Historique:
received:
24
07
2023
accepted:
21
10
2023
medline:
31
10
2023
pubmed:
31
10
2023
entrez:
31
10
2023
Statut:
epublish
Résumé
Exercise intervention research has shown promising results in preventing and reversing the side effects caused by prostate cancer and its' treatment. However, there are still unanswered questions and the need for additional research. As the field of exercise oncology in the context of prostate cancer presents unique challenges and complexities, seeking the advice of experienced exercise oncology researchers before initiating a similar trial could help to design more effective and efficient studies and help avoid pitfalls. A qualitative descriptive study design and a nonprobability, purposive sampling method was employed. An interview guide was developed and included topics such as recruitment, retention, programme goals, research design, health considerations, treatment considerations, adverse events, exercise prescription and outcome tools. Individual semi-structured interviews were conducted and interviews were transcribed and analysed using thematic analysis. Eight individuals with extensive experience working with prostate cancer patients in exercise oncology research settings were interviewed. Four main themes and seven subthemes were generated and supported by the data. Theme 1 highlighted the critical role of recruitment, with associated subthemes on recruitment barriers and recruitment methods. Theme 2 explored the positives and negatives of home-based programmes. Theme 3 focused on specific health characteristics, exercise prescription and outcome measure factors that must be considered when working with prostate cancer cohorts. Finally, theme 4 centered around the emotional dimensions present in exercise oncology trials, relating to both researchers and study participants. Exercise oncology remains a challenging area in which to conduct research. Learning from experienced personnel in the field offers valuable information and guidance that could impact the success of future trials.
Sections du résumé
BACKGROUND
BACKGROUND
Exercise intervention research has shown promising results in preventing and reversing the side effects caused by prostate cancer and its' treatment. However, there are still unanswered questions and the need for additional research. As the field of exercise oncology in the context of prostate cancer presents unique challenges and complexities, seeking the advice of experienced exercise oncology researchers before initiating a similar trial could help to design more effective and efficient studies and help avoid pitfalls.
METHODS
METHODS
A qualitative descriptive study design and a nonprobability, purposive sampling method was employed. An interview guide was developed and included topics such as recruitment, retention, programme goals, research design, health considerations, treatment considerations, adverse events, exercise prescription and outcome tools. Individual semi-structured interviews were conducted and interviews were transcribed and analysed using thematic analysis.
RESULTS
RESULTS
Eight individuals with extensive experience working with prostate cancer patients in exercise oncology research settings were interviewed. Four main themes and seven subthemes were generated and supported by the data. Theme 1 highlighted the critical role of recruitment, with associated subthemes on recruitment barriers and recruitment methods. Theme 2 explored the positives and negatives of home-based programmes. Theme 3 focused on specific health characteristics, exercise prescription and outcome measure factors that must be considered when working with prostate cancer cohorts. Finally, theme 4 centered around the emotional dimensions present in exercise oncology trials, relating to both researchers and study participants.
CONCLUSION
CONCLUSIONS
Exercise oncology remains a challenging area in which to conduct research. Learning from experienced personnel in the field offers valuable information and guidance that could impact the success of future trials.
Identifiants
pubmed: 37904240
doi: 10.1186/s13102-023-00756-7
pii: 10.1186/s13102-023-00756-7
pmc: PMC10614306
doi:
Types de publication
Journal Article
Langues
eng
Pagination
145Subventions
Organisme : Irish Research Council
ID : EBPPG/2020/103
Organisme : Medical Center, University of Pittsburgh
ID : EBPPG/2020/103
Informations de copyright
© 2023. The Author(s).
Références
BMC Cancer. 2019 Apr 5;19(1):321
pubmed: 30953460
Eur Urol Open Sci. 2021 Feb 24;26:55-63
pubmed: 34337508
Eur J Oncol Nurs. 2019 Aug;41:135-142
pubmed: 31358246
Front Physiol. 2019 Jul 03;10:843
pubmed: 31333495
Eur Urol Focus. 2016 Aug;2(3):284-295
pubmed: 28723375
Eur J Cancer Care (Engl). 2006 Sep;15(4):386-96
pubmed: 16968322
PLoS One. 2021 Jun 10;16(6):e0253018
pubmed: 34111218
J Clin Oncol. 2007 Oct 1;25(28):4396-404
pubmed: 17785708
Curr Sports Med Rep. 2021 May 1;20(5):271-276
pubmed: 33908915
Prostate Cancer Prostatic Dis. 2021 Mar;24(1):35-48
pubmed: 32860010
Clin Trials. 2011 Feb;8(1):85-93
pubmed: 21163854
Eur Urol. 2016 Apr;69(4):693-703
pubmed: 26632144
Br Dent J. 2008 Mar 22;204(6):291-5
pubmed: 18356873
Eur J Oncol Nurs. 2019 Aug;41:16-23
pubmed: 31358249
BJU Int. 2015 Feb;115(2):256-66
pubmed: 24467669
J Clin Nurs. 2020 Mar;29(5-6):758-769
pubmed: 31769562
Contemp Clin Trials Commun. 2018 Aug 07;11:156-164
pubmed: 30112460
Qual Life Res. 2016 Dec;25(12):3027-3035
pubmed: 27315118
Cancers (Basel). 2021 Apr 15;13(8):
pubmed: 33921141
Eur Urol. 2020 Jan;77(1):38-52
pubmed: 31493960
Health Technol Assess. 2021 Sep;25(57):1-132
pubmed: 34590577
Trials. 2015 Sep 25;16:428
pubmed: 26407547
Support Care Cancer. 2020 Jul;28(7):3429-3440
pubmed: 31792881
Psychooncology. 2002 Jul-Aug;11(4):307-26
pubmed: 12203744
Acad Med. 2014 Sep;89(9):1245-51
pubmed: 24979285
Rev Bras Enferm. 2018 Jan-Feb;71(1):228-233
pubmed: 29324967
J Clin Oncol. 2006 Sep 20;24(27):4448-56
pubmed: 16983113